Immunoglobulin Replacement Therapy for Patients with CLL - Dr. Jacob Soumerai ASH 2023

Immunoglobulin replacement therapy (IgRT) effectively reduces infection risk in patients with chronic lymphocytic leukemia (CLL). However, more work needs to be done to ensure that more patients get their IgG levels tested and receive immunoglobulin replacement therapy.

Dr. Jacob Soumerai from Massachusetts General Hospital Cancer Center and colleagues presented the results at the American Society for Hematology (ASH) Annual Meeting 2023.

Read the full article on CLL Society's website at: https://cllsociety.org/2024/06/immuno...
__________________________________________________________________________________________
CLL Society Website: https://cllsociety.org/
Facebook:   / cllsociety  
Twitter:   / cllsociety  
LinkedIn:   / cll-society